Cipla News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Cipla from all sources in a single place.

16 Jan 2026, 07:38PM

1397.50

-2.58%

Lanreotide supply disruption raises concerns over Cipla's earnings

Business Standard

Cipla said supplies of its key US drug Lanreotide will remain constrained after its manufacturing partner paused production following USFDA observations

Number of FII/FPI investors decreased from 1124 to 1085 in Sep 2025 qtr

Cipla Ltd.

16 Jan 2026, 05:49PM

1397.50

-2.58%

Company Update

Cipla Ltd - 500087 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018

pdf

Cipla Ltd.

16 Jan 2026, 10:15AM

1397.50

-2.58%

Cipla slips 5%, hits nine-month low; why pharma stock under pressure?

Business Standard

In the past seven trading days, the stock price of Cipla has slipped 11 per cent from 1,530.25 hit on January 1, 2026.

Cipla Ltd. has an average target of 1697.44 from 9 brokers.

Cipla Ltd.

14 Jan 2026

1397.50

-2.58%

Company Update

Cipla Ltd - 500087 - Update On Lanreotide Supply Pursuant To US Food And Drug Administration …

BSE India

Please find enclosed enclosed update on Lanreotide supply

pdf

Cipla Ltd.

09 Jan 2026

1397.50

-2.58%

Earnings Call

Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pursuant to Regulation 30 of Securities and Exchange Baord of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the schedule of Earnings Conference Call to be held on 23rd January, 2026.

pdf

Cipla Ltd.

08 Jan 2026

1397.50

-2.58%

Cipla among 5 F&O stocks with a sharp rise in futures open interest

Economic Times

On January 7, futures open interest rose notably across five F&O stocks, contributing to a cumulative increase of over 10% compared with the previous session. A rise in futures open interest points to a build-up of active contracts, suggesting fresh positioning or expansion of existing positions by traders.

Cipla Ltd. is trading below all available SMAs

Cipla Ltd.

07 Jan 2026

1397.50

-2.58%

Company Update

Cipla Ltd - 500087 - Reply On Clarification Sought By Exchange

BSE India

Reply on clarification sought by Exchange

pdf

Cipla Ltd.

07 Jan 2026

1397.50

-2.58%

Company Update

Cipla Ltd - 500087 - Intimation Under Regulation 30(11) Of The SEBI (Listing Obligations And Disclosure …

BSE India

News clarification enclosed

pdf

Cipla Ltd.

07 Jan 2026

1397.50

-2.58%

Company Update

Cipla Ltd - 500087 - Clarification sought from Cipla Ltd

BSE India

The Exchange has sought clarification from Cipla Ltd on January 07, 2026, with reference to news appeared in https://www.moneycontrol.com/ dated January 07, 2026 quoting "Cipla shares slide 4.5% after USFDA flags compliance gaps at key Lanreotide supplier site" The reply is awaited.